Get the Stockscreener App
0.5858
0.19%
-0.0011
After Hours:
.59
0.0042
+0.72%
Unicycive Therapeutics Inc Stock (UNCY) Forecast
The Unicycive Therapeutics Inc (UNCY) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.5424, representing a -7.42% decrease from the current price of $0.5858. The highest analyst price target is $0.5313, and the lowest is $0.5534.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month UNCY Price Target
Average 0.9448
(+61.28% Upside)
Is Unicycive Therapeutics Inc (UNCY) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 48.94 | Neutral |
| STOCH(9,6) | 61.40 | Neutral |
| STOCHRSI(14) | 62.65 | Neutral |
| MACD(12,26) | -0.00489 | Buy |
| ADX(14) | 24.84 | Neutral |
| William %R | -28.50 | Neutral |
| CCI(14) | 7.7373 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.5849
Buy
|
0.5857
Buy
|
| MA20 |
0.5922
Sell
|
0.5898
Sell
|
| MA50 |
0.595
Sell
|
0.5937
Sell
|
| MA100 |
0.5973
Sell
|
0.5948
Sell
|
| MA200 |
0.5469
Buy
|
0.6527
Sell
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, UNCY could be considered a Moderate Sell, with 17 technical analysis indicators signaling 4 Buy signals, 7 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on UNCY, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 48.94 indicates that UNCY is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 61.4 indicates that UNCY is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 62.65 indicates that UNCY is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.84 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 7.7373 indicates that UNCY is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term UNCY price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Unicycive Therapeutics Inc financial reports and earnings history, Unicycive Therapeutics Inc (UNCY) stock could reach $1.0553 by 2030, $6.73 by 2040 and $11.48 by 2050. See the projected annual prices until 2050 of the Unicycive Therapeutics Inc stock below:
- Unicycive Therapeutics Inc (UNCY) is expected to reach an average price of $4.2444 in 2035, with a high prediction of $4.2254 and a low estimate of $4.1999. This indicates an $624.56% rise from the last recorded price of $0.5858.
- Unicycive Therapeutics Inc (UNCY) stock is projected to chart a bullish course in 2040, with an average price target of $6.84, representing an $1,068% surge from its current level. The forecast ranges from a conservative $2.234 to a sky-high $6.73.
- Our analysts predict Unicycive Therapeutics Inc (UNCY) to jump 821.27% by 2045, soaring from $5.5068 to an average price of $5.3968, potentially reaching $6.8961. While $5.5068 is the low estimate, the potential upside is significant.
- Unicycive Therapeutics Inc (UNCY) stock is expected to climb by 2050, reaching an average of $11.51, a $1,865% jump from its current level. However, a wide range of estimates exists, with high and low targets of $11.48 and $11.51, respectively, highlighting the market's uncertainty.
Unicycive Therapeutics Inc Stock (UNCY) Year by Year Forecast
Unicycive Therapeutics Inc Stock (UNCY) Price Forecast for 2025
Unicycive Therapeutics Inc Stock (UNCY) is expected to reach an average price of $0.3151 in 2025, with a high prediction of $0.5584 and a low estimate of $0.0718. This indicates an -46.21% fall from the last recorded price of $0.5858.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $0.5602 | $0.5534 | $0.5313 | -4.36% |
| August, 2025 | $0.6186 | $0.54 | $0.5476 | +5.60% |
| September, 2025 | $0.5059 | $0.5308 | $0.5525 | -13.64% |
| October, 2025 | $0.4874 | $0.5075 | $0.4902 | -16.80% |
| November, 2025 | $0.4247 | $0.4547 | $0.4069 | -27.49% |
| December, 2025 | $0.5282 | $0.4841 | $0.5584 | -9.84% |
Unicycive Therapeutics Inc Stock (UNCY) Price Forecast for 2026
The predicted value for Unicycive Therapeutics Inc (UNCY) in 2026 is set at an average of $0.9448. Estimates vary from a peak of $1.8148 to a trough of $0.0748, indicating an +61.28% surge from the present price of $0.5858.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.5336 | $0.5706 | $0.50 | -8.91% |
| February, 2026 | $0.5709 | $0.5729 | $0.5366 | -2.55% |
| March, 2026 | $1.0619 | $0.0748 | $1.8148 | +81.27% |
| April, 2026 | $0.3303 | $0.1403 | $1.2545 | -43.62% |
| May, 2026 | $0.348 | $0.2416 | $0.5754 | -40.60% |
| June, 2026 | $0.5257 | $0.3087 | $0.8527 | -10.26% |
| July, 2026 | $0.2246 | $0.0971 | $0.7914 | -61.65% |
| August, 2026 | $0.1041 | $0.1088 | $0.2855 | -82.22% |
| September, 2026 | $0.1924 | $0.1561 | $0.1427 | -67.15% |
| October, 2026 | $0.004 | $0.0949 | $0.169 | -99.32% |
| November, 2026 | $0.2403 | $0.1508 | $0.2144 | -58.98% |
| December, 2026 | $0.3209 | $0.2617 | $0.2915 | -45.23% |
Unicycive Therapeutics Inc Stock (UNCY) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Unicycive Therapeutics Inc (UNCY) is $0.5517, with a high forecast of $1.081 and a low forecast of $0.0224. This indicates an -5.82% decrease from the last price of $0.5858.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.0796 | $0.2281 | $0.1919 | -86.42% |
| February, 2027 | $0.1095 | $0.0224 | $0.2999 | -81.31% |
| March, 2027 | $1.053 | $0.1152 | $1.081 | +79.76% |
| April, 2027 | $0.7457 | $0.4787 | $1.0687 | +27.30% |
| May, 2027 | $0.5285 | $0.4785 | $0.9028 | -9.79% |
| June, 2027 | $0.46 | $0.2531 | $0.6145 | -21.47% |
| July, 2027 | $0.4145 | $0.4745 | $0.4086 | -29.23% |
| August, 2027 | $0.2691 | $0.4091 | $0.1104 | -54.07% |
| September, 2027 | $0.1498 | $0.2877 | $0.3209 | -74.43% |
| October, 2027 | $0.0768 | $0.2309 | $0.1383 | -86.89% |
| November, 2027 | $0.8013 | $0.9354 | $0.7341 | +36.80% |
| December, 2027 | $1.2045 | $1.0199 | $0.9646 | +105.62% |
Unicycive Therapeutics Inc Stock (UNCY) Price Forecast for 2028
In 2028, Unicycive Therapeutics Inc (UNCY) is projected to reach an average price of $1.6677, with a high projection of $1.8686 and a low estimate of $1.4668. This indicates an +184.69% rise from the last price of $0.5858.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.5391 | $1.5391 | $1.4318 | +162.73% |
| February, 2028 | $1.3636 | $1.4736 | $1.4263 | +132.78% |
| March, 2028 | $1.4468 | $1.4668 | $1.4095 | +146.98% |
| April, 2028 | $1.8306 | $1.4854 | $1.6332 | +212.50% |
| May, 2028 | $1.7545 | $1.8145 | $1.8686 | +199.51% |
| June, 2028 | $1.7666 | $1.7003 | $1.7031 | +201.56% |
| July, 2028 | $1.7531 | $1.7563 | $1.7435 | +199.27% |
| August, 2028 | $1.7967 | $1.7422 | $1.7418 | +206.70% |
| September, 2028 | $1.7238 | $1.7783 | $1.7627 | +194.27% |
| October, 2028 | $1.7859 | $1.76 | $1.7562 | +204.86% |
| November, 2028 | $1.579 | $1.7167 | $1.7497 | +169.55% |
| December, 2028 | $1.5914 | $1.6436 | $1.5587 | +171.66% |
Unicycive Therapeutics Inc Stock (UNCY) Price Forecast for 2029
The 2029 price forecast for Unicycive Therapeutics Inc Stock (UNCY) is $0.8605 on average, with a high prediction of $1.6761 and a low estimate of $0.0448. This represents an +46.89% increase from the previous price of $0.5858.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.7068 | $1.5895 | $1.5472 | +191.36% |
| February, 2029 | $1.6413 | $1.6712 | $1.6761 | +180.18% |
| March, 2029 | $1.6258 | $1.6508 | $1.5949 | +177.54% |
| April, 2029 | $0.5696 | $0.9804 | $1.6031 | -2.76% |
| May, 2029 | $0.2836 | $0.0448 | $0.541 | -51.59% |
| June, 2029 | $0.6281 | $0.5422 | $0.5995 | +7.22% |
| July, 2029 | $0.5726 | $0.6454 | $0.584 | -2.24% |
| August, 2029 | $0.5958 | $0.4899 | $0.5558 | +1.71% |
| September, 2029 | $0.6904 | $0.6831 | $0.6804 | +17.85% |
| October, 2029 | $1.0406 | $0.719 | $0.9935 | +77.65% |
| November, 2029 | $1.106 | $1.0522 | $1.0481 | +88.80% |
| December, 2029 | $0.8428 | $0.9626 | $0.844 | +43.88% |
Unicycive Therapeutics Inc Stock (UNCY) Price Forecast for 2030
Unicycive Therapeutics Inc Stock (UNCY) is expected to reach an average price of $1.0119 in 2030, with a high forecast of $1.998 and a low forecast of $0.0258. This signifies an +72.73% surge from the last price of $0.5858.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.1531 | $1.0953 | $1.0553 | +96.84% |
| February, 2030 | $0.9959 | $1.1204 | $1.1023 | +70.00% |
| March, 2030 | $0.7249 | $0.8049 | $0.9676 | +23.74% |
| April, 2030 | $0.5694 | $0.6445 | $0.5887 | -2.79% |
| May, 2030 | $0.0826 | $0.174 | $0.5281 | -85.90% |
| June, 2030 | $0.0528 | $0.0499 | $0.3015 | -90.98% |
| July, 2030 | $0.3303 | $0.0258 | $0.2056 | -43.61% |
| August, 2030 | $2.158 | $0.2276 | $1.998 | +268.38% |
| September, 2030 | $1.7698 | $2.0298 | $1.8923 | +202.11% |
| October, 2030 | $1.9345 | $1.8316 | $1.6657 | +230.24% |
| November, 2030 | $1.5963 | $1.7463 | $1.8477 | +172.51% |
| December, 2030 | $2.3382 | $1.8893 | $1.6424 | +299.14% |
1.89%
3.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):